Prioritizing antiretrovirals for second-line therapy in resource-limited countries.
Naidoo
Kogie
K
D044966:Anti-Retroviral Agents / Q000191:economics / Q000627:therapeutic use*; D003906:Developing Countries; D024882:Drug Resistance, Viral; D015658:HIV Infections / Q000188:drug therapy* / Q000191:economics; D006801:Humans
D044966:Anti-Retroviral Agents